Skip Navigation

European Journal of Heart Failure 2009 11(2):223; doi:10.1093/eurjhf/hfn038
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mouquet, F.
Right arrow Articles by de Groote, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mouquet, F.
Right arrow Articles by de Groote, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

Indication for bromocriptine in peripartum cardiomyopathy

Frederic Mouquet

Department of Cardiology
CHRU Lille, Cardiology
Bvd Pr Leclercq
Lille 59037
France
Tel: +33 320 445 331
Fax: +33 320 446 504
Email: frederic.mouquet@univ-lille2.fr

Nicolas Lamblin

Department of Cardiology
CHRU Lille, Cardiology
Bvd Pr Leclercq
Lille 59037
France

Pascal de Groote

Department of Cardiology
CHRU Lille, Cardiology
Bvd Pr Leclercq
Lille 59037
France

The first 10% of the full text of this article appears below.

We read with great interest the case report of Habedank et al.1 We would like to bring to your attention the fact that the authors overstate the efficacy of bromocriptine in . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?